tiprankstipranks
Can-Fite BioPharma Ltd. (IL:CANF)
TASE:CANF
Israel Market
CANF
Can Fite Bio
RESEARCH TOOLSreports

Can Fite Bio (CANF) Income Statement

3 Followers

Can Fite Bio Income Statement

Last quarter (Q2 2025), Can Fite Bio's total revenue was $101.00K, a decrease of -36.08% from the same quarter last year. In Q2, Can Fite Bio's net income was $-2.44M. See Can Fite Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 438.40K$ 674.00K$ 743.00K$ 810.00K$ 853.00K
Gross Profit
$ 412.42K$ 674.00K$ 743.00K$ 810.00K$ 853.00K
Operating Expenses
$ 11.18M$ 8.80M$ 8.94M$ 10.91M$ 13.70M
Depreciation and Amortization
$ 25.98K$ 7.00K$ 15.00K$ 14.00K$ 14.00K
EBITDA
$ -10.74M$ -8.12M$ -8.18M$ -10.08M$ -12.83M
Operating Income
$ -10.77M$ -8.13M$ -8.20M$ -10.10M$ -12.84M
Other Income/Expenses
$ 132.06K$ 250.00K$ 561.00K$ -77.00K$ 227.00K
Pretax Income
$ -10.64M$ -7.88M$ -7.63M$ -10.17M$ -12.62M
Net Income
$ -10.64M$ -7.88M$ -7.63M$ -10.17M$ -12.60M
Per Share Metrics
Basic EPS
$ -6.46$ 0.00$ -0.01$ -0.01$ -0.03
Diluted EPS
$ -6.46$ 0.00$ -0.01$ -0.01$ -0.03
Weighted Average Shares Outstanding
 1.65M 2.18B 1.28B 815.80M 458.88M
Weighted Average Shares Outstanding (Diluted)
 1.65M 2.18B 1.28B 815.75M 553.08M
Currency in USD

Can Fite Bio Earnings and Revenue History